Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
Neurology|February 3, 2019
Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysisYusuke Yakushiji, Duncan Wilson, Gareth Ambler, et al.
JAMA Psychiatry|February 21, 2014
Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairmentMi Ji Lee, Sang Won Seo, Duk L Na, et al.
Neurobiology of Aging|June 18, 2013
Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairmentHee Jin Kim, Byoung Seok Ye, Cindy W Yoon, et al.
Neurobiology of Aging|August 13, 2013
Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairmentJae-Hyun Park, Sang Won Seo, Changsoo Kim, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Stroke|December 1, 2021
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled TrialZhe Kang Law, Jason P Appleton, Polly Scutt, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 28, 2026
Rates and Risk Factors for Major Adverse Cardiovascular and Cerebrovascular Events after stroke due to intracerebral haemorrhage: systematic review and study-level meta-analysisVega Pratiwi Putri, Neshika Samarasekera, Tom James Moullaali, et al.
Annals of Neurology|March 16, 2013
Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairmentJae-Hyun Park, Sang Won Seo, Changsoo Kim, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
Pageof 32